These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19728335)
1. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer. Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335 [TBL] [Abstract][Full Text] [Related]
2. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
3. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis. Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697 [TBL] [Abstract][Full Text] [Related]
4. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108 [TBL] [Abstract][Full Text] [Related]
5. Nuclear IKKα mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression. Chen WS; Liu LC; Yen CJ; Chen YJ; Chen JY; Ho CY; Liu SH; Chen CC; Huang WC Oncotarget; 2016 Aug; 7(35):56309-56323. PubMed ID: 27409165 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway. Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091 [TBL] [Abstract][Full Text] [Related]
7. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469 [TBL] [Abstract][Full Text] [Related]
8. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway. Zhao L; Zhang Y Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008 [TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
10. [Effect of bear bile powder on STAT3 pathway in hepatocellular carcinoma xenograft]. Zhao JY; Liu LY; Shen AL; Lin W; Cao ZY; Zhuang QC; Hong ZF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):976-81. PubMed ID: 25223184 [TBL] [Abstract][Full Text] [Related]
11. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma. Yeung BH; Shek FH; Lee NP; Wong CK PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933 [TBL] [Abstract][Full Text] [Related]
13. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway. Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111 [TBL] [Abstract][Full Text] [Related]
14. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70. Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405 [TBL] [Abstract][Full Text] [Related]
15. Regulation and function of IKK and IKK-related kinases. Häcker H; Karin M Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224 [TBL] [Abstract][Full Text] [Related]
16. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375 [TBL] [Abstract][Full Text] [Related]
17. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563 [TBL] [Abstract][Full Text] [Related]
19. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
20. Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling. Wang H; Ma D; Wang C; Zhao S; Liu C Med Sci Monit; 2016 May; 22():1827-36. PubMed ID: 27239780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]